Last month, the Drug Enforcement Administration abruptly revoked the narcotics license held by the distributor Cardinal Health, preventing that firm from shipping prescription pain drugs to thousands of Florida pharmacies and hospitals. It's the latest tactic in the DEA's struggle to stem the illicit use of prescription painkillers like OxyContin and Vicodin.

AEI's Danielle Pletka, vice president of foreign and defense policy studies explains in a new post why these negotiations are destined to fail and a new report by AEI Iran expert Ali Alfoneh on Iranian Brigadier General Gholamreza Baghbani, the current chief of Iran's Islamic Revolutionary Guards Corps Quds Force (IRGC QF) office in Zahedan, and a narcotics trafficker.

Since there is no demand for dangerous medicine, international action has a far greater chance of success than the war against narcotics.

In a just-published op-ed in the New York Times, American Enterprise Institute (AEI) international health economist Roger Bate highlights a better way to fight fake pharmaceuticals while still giving poor Americans access to less costly drugs from online pharmacies.

In an attempt to protect poor, uninsured and underinsured Americans from unsafe drugs, we are making sure that some go without drugs completely. It is time the law was changed.

This report describes the extent of its counternarcotics progressand cooperation.

With 100,000 patients dying every year from dangerous medicines, it is time to take concrete actions. Establishing a treaty against fake medicines should be the first step.

There are three things to keep in mind about Kim Jong Il’s death.